2m 2m 2m 2m 2m 2m 2m
ORIC PHARMA (ORIC)
NASDAQ
$8.91+$0.0010 (+0.01%)
Price as of Nov 11, 2026 6:00 PM EST- $923.5MMarket Cap
- -30.82%1-Year Change
- BiotechnologyIndustry
ORIC PHARMA (ORIC)
$8.91+$0.0010 (+0.01%)
ORIC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.91 | ||
Change | -$0.32 (-3.47%) | ||
Open | $9.11 | ||
High | $9.45 | ||
Low | $8.76 | ||
Previous Close | $9.23 | ||
Volume | 1,010,992 | ||
30-Day Average Volume | 1,957,294 | ||
1-Week Change | -7.09% | ||
1-Month Change | -25.69% | ||
1-Year Change | -30.82% | ||
3-Year Change | 42.79% | ||
5-Year Change | -48.17% | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $404.7M | ||
Market Cap | $923.5M | ||
Enterprise Value | $886.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.5M | ||
Free Cash Flow | -$32.0M | ||
EBIT | -$41.5M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $252.9M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -23 | ||
PEG | 2 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue